Dr. Kelly Gebo

powered by
COS Expertise®
Johns Hopkins University
School of Medicine
Medicine
Infectious Diseases, Epidemiology
Associate ProfessorAppointed: 2007
Johns Hopkins University
Krieger School of Arts and Sciences
Public Health
Public Health Studies Program
DirectorAppointed: 2005

Mailing Address

Room 442
1830 E. Monument St.
Baltimore, Maryland 21287
United States

Contact Information

Phone: (410) 502-2325
Fax: (410) 955-7889
kgebo@jhmi.edu

Qualifications

M.P.H., Johns Hopkins University, 2000.
M.D., Johns Hopkins University, 1995.
B.A., Johns Hopkins University, Biology, 1991.

Expertise and Research Interests

Dr. Gebo is an expert in health care utilization in HIV infected patients. She also is interested in disparities in access to care and clinical outcomes in HIV patients. Her current research also focuses on HIV in the older patient.

Keywords

COS Keywords:

Elderly Patients, Geriatrics, Gerontology, Health and Medicine, Health Care, Health of Underserved Populations, HIV, Infectious Diseases or Agents, Internal Medicine, Medical Education, Outcomes Research (Medical), Public Health.

Languages

(Reading, Writing, Speaking)

English: (Fluent, Fluent, Fluent)
Spanish: (Functional, Basic, Functional)

Memberships

American College of Physicians
American Public Health Association
Infectious Diseases Society of America
Society of General Internal Medicine

Previous Positions

1998-2001, Fellow, Johns Hopkins University, School of Medicine, Medicine, Infectious Diseases
1998-2000, Robert Wood Johnson Clinical Scholar, Johns Hopkins University, School of Medicine, Medicine

Funding Received

  • National Institute of Drug Abuse: Health Care Utilization in IDU's, 2001 to 2006.

Publications

  • Gebo KA, Kalyani R, Moore RD, Polydefkis MJ (Oct 2005) The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era., Journal of Acquired Immune Deficiency Syndromes (1999), 40 (2), 169-74 Abstract
  • Fleishman JA, Gebo KA, Reilly ED, Conviser R, Christopher Mathews W, Todd Korthuis P, Hellinger J, Rutstein R, Keiser P, Rubin H, Moore RD, HIV Research Network (Sep 2005) Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002., Medical Care, 43 (9 Suppl), III40-52 Abstract
  • Rutstein RM, Gebo KA, Siberry GK, Flynn PM, Spector SA, Sharp VL, Fleishman JA (Sep 2005) Hospital and outpatient health services utilization among HIV-infected children in care 2000-2001., Medical Care, 43 (9 Suppl), III31-9 Abstract
  • Gebo KA, Fleishman JA, Reilly ED, Moore RD, HIV Research Network (Sep 2005) High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States., Medical Care, 43 (9 Suppl), III23-30 Abstract
  • Rutstein RM, Gebo KA, Flynn PM, Fleishman JA, Sharp VL, Siberry GK, Spector SA (Sep 2005) Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy., Medical Care, 43 (9 Suppl), III15-22 Abstract
  • Betz ME, Gebo KA, Barber E, Sklar P, Fleishman JA, Reilly ED, Christopher Mathews W, HIV Research Network (Sep 2005) Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001., Medical Care, 43 (9 Suppl), III3-14 Abstract
  • Moore RD, Keruly JC, Gebo KA, Lucas GM (Jun 2005) An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002., Journal of Acquired Immune Deficiency Syndromes (1999), 39 (2), 195-8 Abstract
  • Gebo KA, Fleishman JA, Conviser R, Reilly ED, Korthuis PT, Moore RD, Hellinger J, Keiser P, Rubin HR, Crane L, Hellinger FJ, Mathews WC, HIV Research Network, Racial and Gender Disparities in Receipt of Highly Active Antiretroviral Therapy Persist in a Multistate Sample of HIV Patients In 2001., Journal of Acquired Immune Deficiency Syndromes (1999), 38(1), 96-103, Jan 2005 Abstract
  • Harrington SM, Ross TL, Gebo KA, Merz WG, Vancomycin Resistance, Esp, and Strain Relatedness: a 1-year Study Of Enterococcal Bacteremia., Journal of Clinical Microbiology, 42(12), 5895-8, Dec 2004 Abstract
  • Gebo KA, HIV in Patients Over 50: An Increasing Problem., The Hopkins Hiv Report : a Bimonthly Newsletter for Healthcare Providers / Johns Hopkins University Aids Service., 16(6), 7-11, Nov 2004 Abstract
  • Gebo KA, Moore RD (Oct 2004) Treatment of HIV infection in the older patient., Expert Review of Anti-infective Therapy, 2 (5), 733-43 Abstract
  • Mahadevia PJ, Gebo KA, Pettit K, Dunn JP, Covington MT (Aug 2004) The epidemiology, treatment patterns, and costs of cytomegalovirus retinitis in the post-haart era among a national managed-care population., Journal of Acquired Immune Deficiency Syndromes (1999), 36 (4), 972-7 Abstract
  • Gebo KA, Gallant JE, Keruly JC, Moore RD (Aug 2004) Absolute CD4 vs. CD4 percentage for predicting the risk of opportunistic illness in HIV infection., Journal of Acquired Immune Deficiency Syndromes (1999), 36 (5), 1028-33 Abstract
  • Gebo KA, Report From San Francisco: the 11th Conference on Retroviruses And Opportunistic Infections (CROI). Hepatitis: Glimpses of Optimism Tempered By Sobering Mortality Statistics., The Hopkins Hiv Report : a Bimonthly Newsletter for Healthcare Providers / Johns Hopkins University Aids Service., 16(2), 8-9, Mar 2004 Abstract
  • Gebo KA, Bass EB, Liver Biopsy and Screening for Cancer in Hepatitis C., American Family Physician, 68(9), 1719, 1723, 1726, 17, Nov 2003 Abstract
  • Gebo KA, Moore RD, Fleishman JA, The HIV Research Network: a Unique Opportunity for Real Time Clinical Utilization Analysis in HIV., The Hopkins Hiv Report : a Bimonthly Newsletter for Healthcare Providers / Johns Hopkins University Aids Service., 15(6), 5-6, Nov 2003 Abstract
  • Gebo KA, Diener-West M, Moore RD, Hospitalization Rates Differ By Hepatitis C Satus in An Urban HIV Cohort., Journal of Acquired Immune Deficiency Syndromes (1999), 34(2), 165-73, Oct 2003 Abstract
  • Gebo KA, HIV and Hepatitis., The Hopkins Hiv Report : a Bimonthly Newsletter for Healthcare Providers / Johns Hopkins University Aids Service., 15(2), 9-10, Mar 2003 Abstract
  • Gebo KA, Keruly J, Moore RD, Association of Social Stress, Illicit Drug Use, and Health Beliefs With Nonadherence to Antiretroviral Therapy., Journal of General Internal Medicine : Official Journal of the Society for Research and Education in Primary Care Internal Medicine., 18(2), 104-11, Feb 2003 Abstract
  • Chander G, Sulkowski MS, Jenckes MW, Torbenson MS, Herlong HF, Bass EB, Gebo KA, Treatment of Chronic Hepatitis C: a Systematic Review., Hepatology (baltimore, Md.), 36(5 Suppl 1), S135-44, Nov 2002 Abstract
  • Gebo KA, Chander G, Jenckes MW, Ghanem KG, Herlong HF, Torbenson MS, El-Kamary SS, Bass EB, Screening Tests for Hepatocellular Carcinoma in Patients With Chronic Hepatitis C: a Systematic Review., Hepatology (baltimore, Md.), 36(5 Suppl 1), S84-92, Nov 2002 Abstract
  • Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG, El-Kamary SS, Sulkowski M, Bass EB, Role of Liver Biopsy in Management of Chronic Hepatitis C: a Systematic Review., Hepatology (baltimore, Md.), 36(5 Suppl 1), S161-72, Nov 2002 Abstract
  • Gebo KA, Bartlett JG, Management of Hepatitis C: a Review of the NIH Consensus Development Conference., The Hopkins Hiv Report : a Bimonthly Newsletter for Healthcare Providers / Johns Hopkins University Aids Service., 14(5), suppl i-iv, Sep 2002 Abstract
  • Gebo KA, Srinivasan A, Perl TM, Ross T, Groth A, Merz WG, Pseudo-outbreak of Mycobacterium Fortuitum on a Human Immunodeficiency Virus Ward: Transient Respiratory Tract Colonization From a Contaminated Ice Machine., Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America., 35(1), 32-8, Jul 2002 Abstract
  • Gebo KA, Jenckes MW, Chander G, Torbenson MS, Ghanem KG, Herlong HF, Sulkowski MS, El-Kamary SS, Harris KA, Guedelhoefer OC, Bass EB, Management of Chronic Hepatitis C., Evidence Report/technology Assessment (summary), 1-7, Jun 2002 Abstract
  • Gebo KA, Prostatic Tuberculosis in An HIV Infected Male., Sexually Transmitted Infections, 78(2), 147-8, Apr 2002 Abstract
  • Gebo K, HIV and Hepatitis C., The Hopkins Hiv Report : a Bimonthly Newsletter for Healthcare Providers / Johns Hopkins University Aids Service., 14(2), 5-6, Mar 2002 Abstract
  • Lucas GM, Gebo KA, Chaisson RE, Moore RD, Longitudinal Assessment of the Effects of Drug and Alcohol Abuse on HIV-1 Treatment Outcomes in An Urban Clinic., Aids (london, England), 16(5), 767-74, Mar 2002 Abstract
  • Gebo KA, Diener-West M, Moore RD, Hospitalization Rates in An Urban Cohort After the Introduction of Highly Active Antiretroviral Therapy., Journal of Acquired Immune Deficiency Syndromes (1999), 27(2), 143-52, Jun 2001 Abstract
  • Thomas PA, Gebo KA, Hellmann DB, A Pilot Study of Peer Review in Residency Training., Journal of General Internal Medicine : Official Journal of the Society for Research and Education in Primary Care Internal Medicine., 14(9), 551-4, Sep 1999 Abstract
  • Gebo KA, Chaisson RE, Folkemer JG, Bartlett JG, Moore RD, Costs of HIV Medical Care in the Era of Highly Active Antiretroviral Therapy., Aids (london, England), 13(8), 963-9, May 1999 Abstract
  • Gebo KA, Moore RD, Keruly JC, Chaisson RE, Risk Factors for Pneumococcal Disease in Human Immunodeficiency Virus-infected Patients., The Journal of Infectious Diseases, 173(4), 857-62, Apr 1996 Abstract

Profile Details

Last Updated: 10/11/2007

COS Expertise ID #940564
Reference this profile directly: http://myprofile.cos.com/kgebo